Press Releases Archives - Pattern Bioscience

Pattern Bioscience Appoints David Barreca as Vice President of Sales

by Eric Berger | Jul 27, 2026 | Featured • Press Releases

Commercial leader in diagnostics joins Pattern to build US sales organization as the company nears FDA submission of its breakthrough single-cell microbiology platform and launch of the Pneumonia ID/AST Panel. AUSTIN, Texas, July 27, 2026 — Pattern Bioscience, an...

Pattern Bioscience Surpasses 1,000 Samples in Multi-Center Clinical Trial of Rapid Pneumonia Diagnostic

by Kyle Fieleke | Mar 19, 2026 | Featured • Press Releases

Milestone marks the half-way point of enrollment in pivotal U.S. study designed to support 510(k) submission for the first culture-free, rapid phenotypic ID/AST panel for critically ill pneumonia patients AUSTIN, Texas, March 19, 2026 — Pattern Bioscience, an...

Pattern Bioscience Raises $43 Million in Series D Financing to Pursue FDA Clearance for Its Rapid Pneumonia Diagnostic

by Kyle Fieleke | Nov 18, 2025 | Press Releases

Funding led by AMR Action Fund, Illumina Ventures, and Omnimed Capital supports U.S. clinical trial and 510(k) submission for rapid Pneumonia identification and antibiotic susceptibility testing (ID/AST) panel AUSTIN, Texas, November 18, 2025: Pattern Bioscience, an...

Pattern Bioscience Names Carey-Ann Burnham CEO

by Kyle Fieleke | Jan 9, 2025 | Press Releases

Founder and former CEO Nick Arab to transition to CTO and focus on advancing Pattern’s single-cell microbiology technology Austin, TX – January 9, 2025 – Pattern Bioscience, an innovator in rapid diagnostic technologies for bacterial infections, today announced...

Pattern Awarded $22.5M BARDA Contract to Advance Single-Cell Microbiology System and Critical Care Antimicrobial Susceptibility Testing Panels for Pneumonia and Bacteremia

by Kyle Fieleke | Nov 21, 2024 | Featured • Press Releases

Austin, TX – November 21, 2024 – Pattern Bioscience, an innovator in rapid diagnosis and antibiotic susceptibility testing for bacterial infections, today announced it has been awarded a cost-share contract worth up to $40.9 million by the Biomedical Advanced Research...

Pattern Bioscience Selected as Winner of ADLM Disruptive Technology Award

by Kyle Fieleke | Jul 31, 2023 | Featured • Press Releases

AUSTIN, Texas — July 31, 2023 — Pattern Bioscience, Inc., an innovator in rapid diagnosis and antibiotic susceptibility testing (AST) for bacterial infections, today announced that it was named the winner of the Disruptive Technology Award from the Association for...